Statistics

Total Visits

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study13

Select a period of time:

Number of views in the range

Views
A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study7

Views

Views
November 20231
December 20231
January 20242
February 20241
March 20240
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States7
 

Top cities views

Views
Boardman2
Ashburn2
Chicago1
Fort Worth1